Back to search

Article

Abnormal genome-wide DNA methylation induced by cisplatin may contribute to the chemo-resistance of human small cell lung cancer

2019-12-11

Abstract excerpt

<title>Abstract</title> <p>Background: So far, the platinum-based chemotherapy (e.g. cisplatin-etoposide doublet) is still the backbone for SCLC management due to its high respond rate both in LS-SCLC and ES-SCLC. However, cisplatin treatment often results in the development of chemo-resistance, leading to therapeutic failure and becoming the main obstacle to improve the therapeutic efficacy. Currently, little ha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7a69292e-5850-52e4-94e3-7f03419a5351
DOI
10.21203/rs.2.18626/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Abnormal genome-wide DNA methylation induced by cisplatin may contribute to the chemo-resistance of human small cell lung cancerDOI 10.21203/rs.2.18626/v1
Select a neighboring publication to make it the new centre.